|
Clinical impact of BRCA1 and BRCA2 mRNA expression in ovarian cancer. |
| |
|
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - Amgen |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Novartis |
| |
|
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - Vertex |
| |
|
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
| |
|
No Relationships to Disclose |